US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Abeona Therapeutics Inc (ABEO) 銘柄情報

Abeona Therapeutics Inc (ABEO)

6.40

0.35

(5.79%)

終了 7月4日 5:00AM

6.49

0.09

(1.41%)

取引時間後: 8:52AM

Abeona Therapeutics Inc (ABEO) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

6.49

( 7.27% )

買値

4.83

売値

8.02

出来高

1,396,353

6.00 日の範囲 6.42

4.00 52 週間の範囲 7.5401

時価総額

前日終値

6.05

始値

6.09

時刻

最終取引時間

財務取引量

US$ 8,687,738

VWAP

6.2217

平均取引量 (3 か月)

US$ 1,148,391

発行済株式数

56,995,144

配当利回り

PER

6.62

1 株当たり利益 (EPS)

0.91

歳入

14.54M

純利益

66.14M

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The... Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.abeonatherapeutics.com

本社

Cleveland, United States

設立

1974

Abeona Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker ABEO. The last closing price for Abeona Therapeutics was US$6.05. Over the last year, Abeona Therapeutics shares have traded in a share price range of US$ 4.00 to US$ 7.5401.

Abeona Therapeutics currently has 56,995,144 shares in issue. The market capitalisation of Abeona Therapeutics is US$369.90 million. Abeona Therapeutics has a price to earnings ratio (PE ratio) of 6.62.

Form 4 - Statement of changes in beneficial ownership of securities

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, July 01, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.84	14.8672566372	5.65	6.5856	5.515	2015826	5.82284438	CS
4	0.8	14.0597539543	5.69	6.5856	5.24	1328423	5.69024497	CS
12	1.67	34.6473029046	4.82	6.5856	4.81	1167853	5.57509722	CS
26	1.19	22.4528301887	5.3	6.5856	4.23	1198587	5.24270539	CS
52	0.93	16.726618705	5.56	7.5401	4	1219843	5.2912472	CS
156	2.37	57.5242718447	4.12	9.01	2.83	751864	5.36764357	CS
260	4.89	305.625	1.6	9.01	0.1303	882918	3.15756906	CS

ABEO - Frequently Asked Questions (FAQ)

What is the current Abeona Therapeutics Inc share price?

The current share price of Abeona Therapeutics Inc is US$ 6.49

How many Abeona Therapeutics Inc shares are in issue?

Abeona Therapeutics Inc has 56,995,144 shares in issue

What is the market cap of Abeona Therapeutics Inc?

The market capitalisation of Abeona Therapeutics Inc is USD 369.9M

What is the 1 year trading range for Abeona Therapeutics Inc share price?

Abeona Therapeutics Inc has traded in the range of US$ 4.00 to US$ 7.5401 during the past year

What is the PE ratio of Abeona Therapeutics Inc?

The price to earnings ratio of Abeona Therapeutics Inc is 6.62

What is the cash to sales ratio of Abeona Therapeutics Inc?

The cash to sales ratio of Abeona Therapeutics Inc is 23.72

What is the registered address of Abeona Therapeutics Inc?

The registered address for Abeona Therapeutics Inc is 6555 Carnegie Avenue, Cleveland, Ohio, 44103

What is the Abeona Therapeutics Inc website address?

The website address for Abeona Therapeutics Inc is www.abeonatherapeutics.com

Which industry sector does Abeona Therapeutics Inc operate in?

Abeona Therapeutics Inc operates in the Biotechnology & Life Sciences sector

georgie18

georgie18 1年前

ABEO...$5.52...🥳 ... https://www.globenewswire.com/news-release/2025/04/29/3069976/0/en/U-S-FDA-Approves-ZEVASKYN-prademagene-zamikeracel-the-First-and-Only-Cell-Based-Gene-Therapy-for-Patients-with-Recessive-Dystrophic-Epidermolysis-Bullosa-RDEB.html

Mr.Mister

Mr.Mister 1年前

https://investors.abeonatherapeutics.com/press-releases/detail/303/u-s-fda-approves-zevaskyn-prademagene-zamikeracel

barmarty

barmarty 1年前

all this company has down in the last 3years is give their people raises and incentives and bonuses' if you are a long term investor all you get is stock reversals and b/s promises they are 1 step in front of the law. i hope their watching, if not i'll remind them

Monksdream

Monksdream 2年前

Monksdream

Monksdream 2年前

Monksdream

Monksdream 2年前

Awl416

Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Monksdream

Monksdream 2年前

ABEO new 52+week high

Monksdream

Monksdream 2年前

ABEO new 52 week high

Monksdream

Monksdream 2年前

ABEO new 52 week high

Monksdream

Monksdream 2年前

ABEO new 52 week high

Monksdream

Monksdream 2年前

ABEO new 52 week high

Monksdream

Monksdream 2年前

ABEO new 52 week high

Joelzee

Joelzee 3年前

Of course this goes up after I close my position. ??

Invest-in-America

Invest-in-America 4年前

You gots me CONFUSED, Young Lady!! YES, I indeed DID post over there --- which YOU should have IGNORED in the first place!! WHATEVER!!! Bottom line???? GO-GO-GO-BABL and HPCO!!! Those two are where I am 'losing-my-shirt' right now!!

gail

you already posted there silly, so i replied to you there in pm. and yes, i know you cant pm back anymore.

Invest-in-America

Invest-in-America 4年前

O.K., I'll take a look at THAT one right now.

gail

i found it on my…

..

own but got back out, its junk, lol. i was replying to you on the other stock admp.

Invest-in-America

Invest-in-America 4年前

ABEO: It's pronounced like, "ABALONE" (that Fish thing)!!

PS: I got your PM, but can't reply to it. Bottom line, do NOT "invest" in ANY of my stock picks!! (Which is great advice for ME, too!!)

gail

can anyone pronounce …

..

this?

Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL™ Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

gail

nice pop in overnight trading. lets see what she does today.

gail

quiet board but this stock is on the move! grabbed a few today.

stock1ace1

stock1ace1 4年前

$3.69 news data coming within a month

stock1ace1

stock1ace1 4年前

Topline data from the Phase 3 VIITAL™ study of EB-101 in RDEB is on track for late third quarter to early fourth quarter of 2022 upon completion of the last patient monitoring visit, which is expected by mid-September.

stock1ace1

stock1ace1 4年前

Buying $3.01 phase 3 data due anyday 3 mil o/s 3 mill float

Topline data from the Phase 3 VIITAL™ study of EB-101 in RDEB is on track for late third quarter to early fourth quarter of 2022 upon completion of the last patient monitoring visit, which is expected by mid-September.

INFINITI

INFINITI 4年前

We need to get this over $1

INFINITI

INFINITI 4年前

Let’s goooo$$$$

INFINITI

INFINITI 4年前

Looks good here

saj

ClayTrader

ClayTrader 5年前

* * $ABEO Video Chart 02-25-2021 * *

Link to Video - click here to watch the technical chart video

jerseyboy

jerseyboy 5年前

They are MBIO, SIOX, and GTHX. GTHX will be the most successful of the three, as they have a recently-approved drug that will change the face of the use of chemotherapy. It is still amazingly cheap relative to its value, and is an easy three-bagger within at most two years, and probably before that.

CyrusDaVirus

CyrusDaVirus 5年前

Which are those 3?

jerseyboy

jerseyboy 5年前

I had to say goodbye to Abeona earlier this week when its price rose above my basis, as I swore to myself that I would do so if it ever recovered from its rapid decline to $1.00. I split it among three other biopharmas which I think have more immediate prospects of bringing their pipelines to revenue-generating fruition. This is a good company, but I think bringing their pipeline to revenue-generating fruition will take awhile from this point. Michael Amoroso should get a lot of credit for what he's done so far as Abeona's leader. Good luck to all who invest here. You could find a lot worse companies in which to invest.

jerseyboy

jerseyboy 5年前

I like what they're doing and obviously also like the share price movement today. Michael Amoroso should get a lot of credit for the way he was able to turn this situation around.

jerseyboy

jerseyboy 5年前

Apparently from the news today Michael Amoroso does know what he is doing. I had a feeling that they were down but not out. I have a good feeling about the gradual and successful development of their pipeline.

Golden Cross

Golden Cross 5年前

jerseyboy

jerseyboy 5年前

The share price is certainly showing a nice steady increase.

Golden Cross

Golden Cross 5年前

Chart looks to be a nice steady incline here

jerseyboy

jerseyboy 5年前

With today's advance, this has almost doubled from the level to where it fell when the CEO and five directors simultaneously resigned. Hopefully the price advance reflects positive things that Michael Amoroso is doing to develop the company. I've held all my shares through the downturn, and have confidence in his background and the company's pipeline.

Golden Cross

Golden Cross 5年前

strong chart here

jerseyboy

jerseyboy 6年前

I feel like people are sleeping on this one. It was a major shock from which to recover to have the CEO and half of the board resign, but I think Michael Amoroso knows what he is doing and is doing a good job in moving the company forward, and I believe that there is good long-term potential here.

railrider

railrider 6年前

News just out spiking up on it

jerseyboy

jerseyboy 6年前

Wow - nice jump today - up 17%! It's still a long way to my basis of $2.98 per share, but something is afoot here with the kind of volume we saw today.

jerseyboy

jerseyboy 6年前

Nice jump today and up over 50% from its low. Let's hope Michael Amoroso can do something here with the assets and the pipeline. He's certainly got the background to be able to bring it forward.

ClayTrader

ClayTrader 6年前

* * $ABEO Video Chart 11-11-2020 * *

Link to Video - click here to watch the technical chart video

whytestocks

whytestocks 6年前

Breaking News: $ABEO What Are The Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch

3 Biotech Penny Stocks to Watch in 2020 Biotech penny stocks have become some of the most popular choices for all types of investors. Both institutional and retail investors have been working to seek gains in the biotech industry. Since the beginning of the year, investors have turn...

Got this from ABEO - What Are The Best Penny Stocks To Buy Now? 3 Biotech Stocks To Watch

realfast95

realfast95 6年前

2x813008 shares free options for 1 year, to two directors
WTF

realfast95

realfast95 6年前

On September 17, 2020, Abeona Therapeutics Inc. (the “Company”) had filed a Current Report on Form 8-K reporting that Steven H. Rouhandeh had notified the Company of his resignation from the Board of Directors (the “Board”), effective September 30, 2020. On September 30, 2020, Mr. Rouhandeh rescinded his resignation from the Board, and the Board accepted his rescission of resignation. Also on September 30, 2020, the Board voted unanimously to elect Mr. Rouhandeh as Chairman of the Board. Mr. Rouhandeh will not be taking on any additional compensation as Chairman other than what he was already receiving as a non-employee director, which such compensation is disclosed in the Company’s proxy statement filed on April 10, 2020.

8k

whytestocks

whytestocks 6年前

BREAKING NEWS: $ABEO Abeona Therapeutics' Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan

Steven H. Rouhandeh Appointed as Chairman of the Board of Directors Jefferies LLC R etained as F inancial A dvisor to A ssist with the R eview of S trategic O ptions NEW YORK and CLEVELAND, Oct. 06, 2020 (GLOBE NEWSWI...

Find out more ABEO - Abeona Therapeutics' Board of Directors Forms Special Committee to Oversee Operations, Develop Strategic Direction and Leadership Plan

realfast95

realfast95 6年前

Steven Rouhandeh
Founder,Chairman and Chief Investment Officer at SCO Capital Partners
Location: United States

Mr. Steven H. Rouhandeh, also known as Steve, J.D., is the Founder of SCO Capital Partners, LLC and has been its Chairman and Chief Investment Officer since 1997. Mr. Rouhandeh is the Founder of SCO Financial Group, LLC and serves as its Chairman. He has been an Executive Chairman at PlasmaTech Biopharmaceuticals, Inc. since March 4, 2008 and has been its Principal Executive Officer since January 1, 2015.

Abeona Therapeutics

Tingyi (Cayman Islands)

Aberforth Split Level In...

Amundi Luxembourg

Mediobanca Banca di Cred...

Compagnia Dei Caraibi

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。